Last reviewed · How we verify
Capurid (CAPURIDE)
Capurid (generic name: CAPURIDE) is a drug. It is currently in Phase 2 development.
Capurid works by binding to specific proteins or receptors in the body, altering their function and leading to a therapeutic effect.
Capurid, also known as CAPURIDE, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a small molecule, it is likely to work by interacting with specific biological pathways, but the exact mechanism is unknown. Further research is needed to determine its efficacy and safety profile. Its current ownership and off-patent status are also unknown.
-
Baseline phase 2 → approval rate
+15.3pp
Industry-wide phase 2 drugs reach approval ~15.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2031–2034 | — |
| EMA | EU | 2032–2035 | +0.7 yr |
| MHRA | GB | 2032–2035 | +0.7 yr |
| Health Canada | CA | 2032–2036 | +0.9 yr |
| TGA | AU | 2032–2036 | +1.2 yr |
| PMDA | JP | 2032–2036 | +1.5 yr |
| NMPA | CN | 2033–2037 | +2.3 yr |
| MFDS | KR | 2032–2036 | +1.4 yr |
| CDSCO | IN | 2032–2037 | +1.8 yr |
| ANVISA | BR | 2033–2037 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | CAPURIDE |
|---|---|
| Modality | Small molecule |
| Therapeutic area | Bone |
| Phase | Phase 2 |
Mechanism of action
Imagine your body's cells are like a orchestra, and proteins are like the musicians. Capurid is like a conductor that helps the musicians play in harmony, but instead of music, it's the proteins that work together to keep you healthy. By binding to these proteins, Capurid can help fix problems in the body, like a doctor prescribing a treatment to fix a broken bone.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Capurid CI brief — competitive landscape report
- Capurid updates RSS · CI watch RSS
Frequently asked questions about Capurid
What is Capurid?
How does Capurid work?
What is the generic name of Capurid?
What development phase is Capurid in?
Related
- Therapeutic area: All drugs in Bone
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing